Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

USP12-induced gene expression in lung adenocarcinoma cells

ABSTRACT: USP12-induced gene expression in lung adenocarcinoma cells

PROVIDER: PRJNA659656 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12532332_1.fastq.gz	Fastqsanger.gz
	SRR12532332_2.fastq.gz	Fastqsanger.gz
	SRR12532333_1.fastq.gz	Fastqsanger.gz
	SRR12532333_2.fastq.gz	Fastqsanger.gz
	SRR12532334_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Hypoxia induced gene expression in lung adenocarcinoma cells

Project description:Two lung adenocarcinoma cell lines, A549 and SPC-A1, were cultured under two different oxygen concentrations, 1% and 20%, respectively. After 24 hours cultured, cells were collected and total RNA was extracted. Affymetrix GeneChip® Gene 1.0 ST Array System for Human was applied to detect the differences of gene expression of lung adenocarcinoma cell lines cultured under different oxygen concentrations (total RNA of the two cells was pooled with equal quantity). The experiments were repeated with the same procedures except culturing tumor cell lines in matrigel.

2015-04-30 | E-MTAB-3512 | biostudies-arrayexpress

Lung adenocarcinoma UNC0638 gene expression

Project description:Lung adenocarcinoma UNC0638 gene expression

| PRJNA491480 | ENA

Ito2019 - gefitnib resistance of lung adenocarcinoma caused by MET amplification

Project description:The model is based on publication: Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification Abstract: Gefitinib, one of the tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR), is effective for treating lung adenocarcinoma harboring EGFR mutation; but later, most cases acquire a resistance to gefitinib. One of the mechanisms conferring gefitinib resistance to lung adenocarcinoma is the amplification of the MET gene, which is observed in 5–22% of gefitinib-resistant tumors. A previous study suggested that MET amplification could cause gefitinib resistance by driving ErbB3-dependent activation of the PI3K pathway. In this study, we built a mathematical model of gefitinib resistance caused by MET amplification using lung adenocarcinoma HCC827-GR (gefitinib resistant) cells. The molecular reactions involved in gefitinib resistance consisted of dimerization and phosphorylation of three molecules, EGFR, ErbB3, and MET were described by a series of ordinary differential equations. To perform a computer simulation, we quantified each molecule on the cell surface using flow cytometry and estimated unknown parameters by dimensional analysis. Our simulation showed that the number of active ErbB3 molecules is around a hundred-fold smaller than that of active MET molecules. Limited contribution of ErbB3 in gefitinib resistance by MET amplification is also demonstrated using HCC827-GR cells in culture experiments. Our mathematical model provides a quantitative understanding of the molecular reactions underlying drug resistance.

2024-09-02 | BIOMD0000000827 | BioModels

Epithelial signatures of chemical-induced lung adenocarcinoma

Project description:Epithelial signatures of chemical-induced lung adenocarcinoma

| PRJNA375075 | ENA

Gene expression from mouse lung adenocarcinoma-associated CD4 cells

Project description:Gene expression from mouse lung adenocarcinoma-associated CD4 cells

| PRJNA505151 | ENA

Gene expression signatures for lung adenocarcinoma

Project description:Gene expression signatures for lung adenocarcinoma

| PRJNA590980 | ENA

Transcriptomic analyses of lung adenocarcinoma cells

Project description:Transcriptomic analyses of lung adenocarcinoma cells

| PRJNA843347 | ENA

MeRIP-sequencing in lung adenocarcinoma cells

Project description:MeRIP-sequencing in lung adenocarcinoma cells

| PRJNA719778 | ENA

expression data from human lung adenocarcinoma cells A549

Project description:expression data from human lung adenocarcinoma cells A549

| PRJNA411770 | ENA

Analysis of gene expression in lung adenocarcinoma cells following ectopic expression of proliferation-suppressive lncRNAs (PSLR).

Project description:RNA-sequencing was performed to gain insight into the transcriptome-wide molecular changes induced by FAM198B-AS1 (PSLR-1) or SEPTIN9-DT (PSLR-2) ectopic expression in lung adenocarcinoma cells. Following expression of PSLR-1 or PSLR-2 lncRNA or control RNA, RNA-sequencing was performed. This high-throughput data revealed elevated expression of these lncRNAs reduced the expression of genes and pathways known to induce proliferation in lung adenocarcinoma cells.

2022-06-22 | GSE169186 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data